Our working hypothesis was that such fibro-inhibitory role of somatostatin may alter the pro-tumor activity of CAFs present in cancers where a desmoplasic reaction is prominent, including pancreatic cancer. The gene discussed is SST; the disease is pancreatic neoplasm.